Logo image of CTEV

CLARITEV CORP (CTEV) Stock Price, Forecast & Analysis

USA - NYSE:CTEV - US62548M2098 - Common Stock

45.28 USD
+2.99 (+7.07%)
Last: 11/19/2025, 9:39:48 AM

CTEV Key Statistics, Chart & Performance

Key Statistics
Market Cap745.76M
Revenue(TTM)930.62M
Net Income(TTM)-662.92M
Shares16.47M
Float7.60M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-20.48
PEN/A
Fwd PEN/A
Earnings (Next)02-23 2026-02-23/bmo
IPO2020-02-10
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology


CTEV short term performance overview.The bars show the price performance of CTEV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 -40

CTEV long term performance overview.The bars show the price performance of CTEV in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of CTEV is 45.28 USD. In the past month the price decreased by -35.92%.

CLARITEV CORP / CTEV Daily stock chart

CTEV Latest News, Press Relases and Analysis

CTEV Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 36.73 44.85B
DOCS DOXIMITY INC-CLASS A 29.19 8.97B
WAY WAYSTAR HOLDING CORP 26.07 6.67B
HTFL HEARTFLOW INC N/A 2.28B
CERT CERTARA INC 16.27 1.31B
SDGR SCHRODINGER INC N/A 1.26B
TDOC TELADOC HEALTH INC N/A 1.24B
PHR PHREESIA INC N/A 1.17B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.06B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP 625.25 1.06B
GDRX GOODRX HOLDINGS INC-CLASS A 7.97 969.39M
HSTM HEALTHSTREAM INC 36.18 729.14M

About CTEV

Company Profile

CTEV logo image Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.

Company Info

CLARITEV CORP

7900 Tysons One Place, Suite 400

McLean VIRGINIA US

Employees: 2700

CTEV Company Website

CTEV Investor Relations

Phone: 12127802000

CLARITEV CORP / CTEV FAQ

Can you describe the business of CLARITEV CORP?

Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.


Can you provide the latest stock price for CLARITEV CORP?

The current stock price of CTEV is 45.28 USD. The price increased by 7.07% in the last trading session.


Does CTEV stock pay dividends?

CTEV does not pay a dividend.


How is the ChartMill rating for CLARITEV CORP?

CTEV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists CTEV stock?

CTEV stock is listed on the New York Stock Exchange, Inc. exchange.


Is CLARITEV CORP (CTEV) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CTEV.


What is the expected growth for CTEV stock?

The Revenue of CLARITEV CORP (CTEV) is expected to grow by 1.46% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


CTEV Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CTEV Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CTEV. CTEV has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CTEV Financial Highlights

Over the last trailing twelve months CTEV reported a non-GAAP Earnings per Share(EPS) of -20.48. The EPS increased by 67.52% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -13.07%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%82.56%
Sales Q2Q%6.71%
EPS 1Y (TTM)67.52%
Revenue 1Y (TTM)-3.21%

CTEV Forecast & Estimates

9 analysts have analysed CTEV and the average price target is 78.2 USD. This implies a price increase of 72.7% is expected in the next year compared to the current price of 45.28.

For the next year, analysts expect an EPS growth of 77.63% and a revenue growth 1.46% for CTEV


Analysts
Analysts84.44
Price Target78.2 (72.7%)
EPS Next Y77.63%
Revenue Next Year1.46%

CTEV Ownership

Ownership
Inst Owners40.19%
Ins Owners6.91%
Short Float %6.93%
Short Ratio3.3